Tower Research Capital (TRC)’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $287K | Buy |
14,691
+14,007
| +2,048% | +$416K | 0.01% | 1334 |
|
|
2025
Q4 | $21.3K | Sell |
684
-3,052
| -82% | -$83.7K | ﹤0.01% | 3057 |
|
|
2025
Q3 | $80.6K | Sell |
3,736
-12,491
| -77% | -$225K | ﹤0.01% | 2175 |
|
|
2025
Q2 | $227K | Buy |
16,227
+14,549
| +867% | +$197K | 0.01% | 1662 |
|
|
2025
Q1 | $22.9K | Sell |
1,678
-32,494
| -95% | -$553K | ﹤0.01% | 2833 |
|
|
2024
Q4 | $655K | Buy |
34,172
+30,475
| +824% | +$663K | 0.01% | 887 |
|
|
2024
Q3 | $84.1K | Sell |
3,697
-6,097
| -62% | -$99.7K | ﹤0.01% | 2356 |
|
|
2024
Q2 | $127K | Buy |
9,794
+8,698
| +794% | +$120K | ﹤0.01% | 2408 |
|
|
2024
Q1 | $19.2K | Sell |
1,096
-1,235
| -53% | -$23.9K | ﹤0.01% | 3036 |
|
|
2023
Q4 | $50.8K | Sell |
2,331
-6,821
| -75% | -$108K | ﹤0.01% | 3127 |
|
|
2023
Q3 | $140K | Buy |
9,152
+4,199
| +85% | +$80.1K | ﹤0.01% | 1718 |
|
|
2023
Q2 | $118K | Buy |
4,953
+1,735
| +54% | +$44.5K | ﹤0.01% | 1926 |
|
|
2023
Q1 | $82K | Buy |
3,218
+3,055
| +1,874% | +$98K | ﹤0.01% | 2054 |
|
|
2022
Q4 | $5K | Sell |
163
-8,010
| -98% | -$185K | ﹤0.01% | 4924 |
|
|
2022
Q3 | $167K | Buy |
8,173
+5,345
| +189% | +$96.1K | ﹤0.01% | 2103 |
|
|
2022
Q2 | $33K | Buy |
2,828
+350
| +14% | +$4.7K | ﹤0.01% | 3284 |
|
|
2022
Q1 | $45K | Buy |
2,478
+2,477
| +247,700% | +$47.6K | ﹤0.01% | 2825 |
|
|
2021
Q4 | $0 | Buy |
+1
| New | +$19 | ﹤0.01% | 6601 |
|
|
2021
Q2 | – | Sell |
-118
| Closed | -$2K | – | 5876 |
|
|
2021
Q1 | $2K | Sell |
118
-1,274
| -92% | -$23.9K | ﹤0.01% | 5054 |
|
|
2020
Q4 | $23K | Buy |
1,392
+1,234
| +781% | +$18.6K | ﹤0.01% | 3785 |
|
|
2020
Q3 | $1K | Buy |
+158
| New | +$2.35K | ﹤0.01% | 4738 |
|
|
2019
Q3 | – | Sell |
-712
| Closed | -$22K | – | 4541 |
|
|
2019
Q2 | $22K | Buy |
712
+311
| +78% | +$12.5K | ﹤0.01% | 2130 |
|
|
2019
Q1 | $17K | Buy |
401
+74
| +23% | +$3.35K | ﹤0.01% | 2377 |
|
|
2018
Q4 | $15K | Sell |
327
-85
| -21% | -$4.92K | ﹤0.01% | 2177 |
|
|
2018
Q3 | $34K | Buy |
412
+211
| +105% | +$19.9K | ﹤0.01% | 2002 |
|
|
2018
Q2 | $19K | Sell |
201
-644
| -76% | -$68.1K | ﹤0.01% | 2475 |
|
|
2018
Q1 | $89K | Buy |
+845
| New | +$91.8K | 0.01% | 1338 |
|
|
2017
Q4 | – | Sell |
-102
| Closed | -$14K | – | 4066 |
|
|
2017
Q3 | $14K | Buy |
+102
| New | +$17.2K | ﹤0.01% | 2926 |
|
|
2015
Q4 | – | Sell |
-3
| Closed | -$578 | – | 5099 |
|
|
2015
Q3 | $1K | Buy |
+3
| New | +$1.05K | ﹤0.01% | 3687 |
|
|
2015
Q2 | – | Sell |
-36
| Closed | -$17K | – | 5077 |
|
|
2015
Q1 | $17K | Buy |
36
+27
| +300% | +$15.6K | ﹤0.01% | 2387 |
|
|
2014
Q4 | $5K | Hold |
9
| – | – | ﹤0.01% | 2746 |
|
|
2014
Q3 | $9K | Buy |
+9
| New | +$10.6K | ﹤0.01% | 2908 |
|
Other funds holding VRDN
BG
VCM
FFM
VA
PBA
